'clerking team that exhibits 'perfect communication''
Legal 500 2008
'Practical and helpful clerks" provide a "smooth and personable service.'
Chambers and Partners 2011
'A number of great IT and telecoms barristers.'
Legal 500 2010
'excellence on IT matters'
Legal 500 (Information Technology) 2010
'Top drawer IP set.'
Legal 500 2010
'A veritable powerhouse of IP expertise'
Chambers and Partners 2011
'outstanding IP chambers'
Legal 500 2008
'8 New Square successfully parlays its renowned IP expertise into success in the IT sector.'
Chambers & Partners (Information Technology) 2009
'An incredibly good set for IP matters'.
Legal 500 2010
Actavis v Novartis [2010] EWCA Civ 82
Case Summary | Judgment | 7 February 2010
This was the appeal in the action to revoke Novartis’ patent for its LESCOL® sustained release fluvastatin product. Richard Meade and Mark Chacksfield were instructed by Novartis. The appeal focused in detail on the requirements set down by the House of Lords in the recent Angiotech decision on the question of assessing inventive step.